title: [Is it possible to detect Staphylococcus aureus colonization or bacteriuria before orthopedic surgery hospitalization?].
abstract: OBJECTIVE
  Evaluate the feasibility of Staphylococcus aureus nasal colonization and bacteriuria screening in outpatients before realizing a decolonization treatment in S. aureus carriers and a bacteriuria treatment before hospitalization.
  
  
  METHODS
  All patients undergoing hip, knee or back surgery in which prosthesis were implanted between October 2007 until the end of June 2008 were included. Microbiological studies were performed before hospitalization. Notice for S. aureus decolonization regimen was delivered to each patient and to the general practitioner only if the patient had nasal carriage.
  
  
  RESULTS
  Only 91.2% (240/263) of patients had microbiological results. Prevalence of S. aureus colonization was 21.4% (48 positives/224). Three patients were colonized with methicillin-resistant staphylococci. Decolonization regimen was applied before surgery to 70.8% (n=34) of the colonized patients. Among the patients, 8.9% (20/225) had bacteriuria, Escherichia coli being the most frequent micro-organism (n=16).
  
  
  CONCLUSIONS
  Preoperative search and management of S. aureus colonization and of bacteriuria in outpatients is possible. Monitoring record must be performed by a member of the hospital staff.
authors.affiliation: Service de bactériologie-virologie-hygiène, CHU de Reims, rue du Général-Koenig, 51100 Reims, France. obajolet@chu-reims.fr
authors.forename: O
authors.initials: O
authors.lastname: Bajolet
authors.forename: E
authors.initials: E
authors.lastname: Toussaint
authors.forename: S
authors.initials: S
authors.lastname: Diallo
authors.forename: V
authors.initials: V
authors.lastname: Vernet-Garnier
authors.forename: E
authors.initials: E
authors.lastname: Dehoux
mesh_terms: D000368:Aged; D019643:Arthroplasty, Replacement; D001437:Bacteriuria / Q000175:diagnosis* / Q000382:microbiology; D002353:Carrier State / Q000175:diagnosis* / Q000382:microbiology / Q000652:urine; D002710:Chlorhexidine / Q000008:administration & dosage / Q000494:pharmacology; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000652:urine; D003428:Cross Infection / Q000517:prevention & control; D003666:Decontamination; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification*; D005240:Feasibility Studies; D005260:Female; D005568:Forms and Records Control; D006760:Hospitalization; D006801:Humans; D008297:Male; D008499:Medical Records; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification; D008875:Middle Aged; D016712:Mupirocin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D009296:Nasal Cavity / Q000382:microbiology*; D011300:Preoperative Care; D012867:Skin / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000175:diagnosis* / Q000517:prevention & control / Q000652:urine; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification*
chemical_list: D016712:Mupirocin; D002710:Chlorhexidine